Dr Hayley Luxton
@HayleyJLuxton
Senior Research Impact & Intelligence Manager at Prostate Cancer UK. All comments are my own. (She/They)
ID:1916658134
29-09-2013 09:15:21
1,3K Tweets
410 Followers
952 Following
1 week to go until our biggest in-person event for Prostate Cancer UK funded researchers!
Excited doesn't quite cover it!!
Fab new work from a team led by Daniel Brewer, David Wedge, Prof. Colin Cooper and Prof. Ros Eeles in Cell Genomics showing that #prostatecancer evolves in two distinct types
What could this mean for our understanding of men's risk?
Grab a โ and read: bit.ly/3IRAmJx
๐ข What role do novel therapeutics that block persistent androgen receptor signalling have in castrate-resistant #prostatecancer ?
Congrats Adam Sharp and team The ICR and beyond, publishing in Molecular Cancer Therapeutics
Grab a โand read: bit.ly/3IGJr7U
Great to see work we've supported through our Research Innovation Awards published in Journal of Clinical Oncology & featuring in the news!
Congrats to Prof Jayne Tierney &team based at MRC Clinical Trials Unit at UCL ๐
'Cancer docs said I had two years to live - I'm still here 13 years later' express.co.uk/life-style/heaโฆ
These planning sessions have been invaluable in shaping From Ideas to Innovation! It's also been a lot of fun in getting to know Prostate Cancer UK's funded researchers a little better ๐ฉต
prostatecanceruk.org/research/for-rโฆ
Our From Ideas to Innovation researcher event is fast approaching!
And as it's a meeting for researchers designed by researchers, we set up planning sessions to discuss how to best convey our researcher's work and encourage collaboration.
#ProstateCancer UK l #ProstateCancer
A team of researchers UEA Research are developing nanoparticles to deliver chemotherapy to men with advanced prostate cancer to make the treatment more effective. ๐
You can read about the huge impact of these tiny particles here: bit.ly/3OcAs2a
Development of isoform-specific antibodies is essential for studying diverse targets in #prostatecancer
Adam Sharp, Johann de Bono and team @ICR_london have risen to the task, reporting a nuclear isoform-specific antibody in Laboratory Investigation
โ๐Read: bit.ly/3GyXJ9T
What role could 3D pathology play in the future of #prostatecancer diagnosis and treatment?๐ฌ
Amazing collaborative effort by NIHR Oxford Biomedical Research Centre and global colleagues - showing some of the advantages and challenges of 3D pathology!
Grab a โand click the link: bit.ly/3v7Spb6